Profile for South Korea Patent: 102412690
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for South Korea Patent: 102412690
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Feb 3, 2037 | Taiho Oncology | LONSURF | tipiracil hydrochloride; trifluridine |
| ⤷ Start Trial | Feb 3, 2037 | Taiho Oncology | LONSURF | tipiracil hydrochloride; trifluridine |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
